相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
Sudhakar Agnihothram et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
Bart L. Haagmans et al.
LANCET INFECTIOUS DISEASES (2014)
Antibodies against MERS Coronavirus in Dromedaries, United Arab Emirates, 2003 and 2013
Benjamin Meyer et al.
EMERGING INFECTIOUS DISEASES (2014)
Broadly Neutralizing Antiviral Antibodies
Davide Corti et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013
R Perera et al.
Eurosurveillance (2013)
Coronaviruses in bats from Mexico
S. J. Anthony et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
Kwok-Hung Chan et al.
JOURNAL OF INFECTION (2013)
Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies
Fei Song et al.
JOURNAL OF VIROLOGY (2013)
The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
Huihui Mou et al.
JOURNAL OF VIROLOGY (2013)
The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies
Stefanie Gierer et al.
JOURNAL OF VIROLOGY (2013)
Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study
Matthew Cotten et al.
LANCET (2013)
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
Romulus Breban et al.
LANCET (2013)
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
Chantal B. E. M. Reusken et al.
LANCET INFECTIOUS DISEASES (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
Darryl Falzarano et al.
NATURE MEDICINE (2013)
Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
Abdullah Assiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Family Cluster of Middle East Respiratory Syndrome Coronavirus Infections
Ziad A. Memish et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
Lanying Du et al.
PLOS ONE (2013)
Human Betacoronavirus 2c EMC/2012-related Viruses in Bats, Ghana and Europe
Augustina Annan et al.
EMERGING INFECTIOUS DISEASES (2013)
The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease
C. T. Watson et al.
GENES AND IMMUNITY (2012)
Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus
Mridula Rani et al.
JOURNAL OF VIROLOGY (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
Davide Corti et al.
SCIENCE (2011)
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene Rearrangements
Scott D. Boyd et al.
JOURNAL OF IMMUNOLOGY (2010)
Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
Barry Rockx et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Therapeutic antibodies, vaccines and antibodyomes
Dimiter S. Dimitrov
MABS (2010)
B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure
Patrizia Farci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge
Barry Rockx et al.
JOURNAL OF VIROLOGY (2008)
Rapid cloning of high-affinity human monoclonal antibodies against influenza virus
Jens Wrammert et al.
NATURE (2008)
Lentivirus Display: Stable Expression of Human Antibodies on the Surface of Human Cells and Virus Particles
Ran Taube et al.
PLOS ONE (2008)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
Mark Throsby et al.
PLOS ONE (2008)
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
Arun K. Kashyap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity
A. B. H. Bakker et al.
VACCINE (2008)
Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway
Jianhua Sui et al.
PLOS PATHOGENS (2008)
The growth and potential of human antiviral monoclonal antibody therapeutics
Wayne A. Marasco et al.
NATURE BIOTECHNOLOGY (2007)
Human Anti-CXCR4 antibodies undergo VH replacement, exhibit functional V-region sulfation, and define CXCR4 antigenic heterogeneity
Chen Xu et al.
JOURNAL OF IMMUNOLOGY (2007)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Molecular identification and phylogenetic analysis of baculoviruses from Lepidoptera
JA Jehle et al.
VIROLOGY (2006)
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus
LH Gould et al.
JOURNAL OF VIROLOGY (2005)
Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2
WH Li et al.
EMBO JOURNAL (2005)
Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China
JF He et al.
SCIENCE (2004)
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
CC Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
JH Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients
H Hofmann et al.
JOURNAL OF VIROLOGY (2004)
VH1-69 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen
CH Chan et al.
BLOOD (2001)
Paramagnetic proteoliposomes containing a pure, native, and oriented seven-transmembrane segment protein, CCR5
T Mirzabekov et al.
NATURE BIOTECHNOLOGY (2000)
分享论文
